Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL3857705

O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F.c1nc(N2CCN(C3CCCCC3)CC2)c2cc(-c3cn[nH]c3)ccc2n1

nearest known ligand 0.53

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.53
HRH3 Q9Y5N1 2/20 0.48
HRH1 P35367 1/20 0.48
CYP3A4 P08684 4/20 0.45
HPGD P15428 1/20 0.45
CLK4 Q9HAZ1 4/20 0.43
ALDH1A1 P00352 4/20 0.43
CYP1A2 P05177 4/20 0.43
HSD17B10 Q99714 2/20 0.43
CYP2C9 P11712 1/20 0.43
KDM4E B2RXH2 2/20 0.42
LMNA P02545 1/20 0.42
GLA P06280 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
DYRK1A Q13627 3/20 0.42
ROCK2 O75116 1/20 0.42
HIF1A Q16665 2/20 0.41
MTNR1B P49286 1/20 0.41
USP2 O75604 2/20 0.41
TSHR P16473 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3852124 0.84 AKT1 (0.57) AKT1CYP3A4HPGDCLK4ALDH1A1
SCHEMBL13874605 0.83 AKT1 (0.49) AKT1HRH3HRH1CYP3A4HPGD
Trifluoroacetic Acid SCHEMBL3851562 0.83 AKT1 (0.55) AKT1CYP3A4HPGDCLK4ALDH1A1
Trifluoroacetic Acid SCHEMBL5852383 0.83 AKT1 (0.55) AKT1CYP3A4HPGDCLK4ALDH1A1
Hydrochloric Acid SCHEMBL3846041 0.82 AKT1 (0.49) AKT1HRH3HRH1CYP3A4HPGD
Trifluoroacetic Acid SCHEMBL3845878 0.82 AKT1 (0.56) AKT1CYP3A4HPGDCLK4ALDH1A1
Trifluoroacetic Acid SCHEMBL3855290 0.82 AKT1 (0.54) AKT1CYP3A4HPGDCLK4ALDH1A1
Trifluoroacetic Acid SCHEMBL3847292 0.82 AKT1 (0.65) AKT1CYP3A4HPGDCLK4ALDH1A1
Trifluoroacetic Acid SCHEMBL3848208 0.82 AKT1 (0.53) AKT1CYP3A4HPGDCLK4ALDH1A1
Trifluoroacetic Acid SCHEMBL3850032 0.82 AKT1 (0.53) AKT1CYP3A4HPGDCLK4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed